Study: Three-in-one vaccine shows promise against ‘tripledemic’

AI-designed universal coronavirus vaccine shows promise in first human trial

A British research partnership points the way on antigen design

Nanoliposome-based subunit vaccine platform targets multiple respiratory viruses simultaneously

Seasonal influenza viruses, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and respiratory syncytial virus (RSV) drive substa

<![CDATA[Single-Shot Respiratory Vaccine Could Transform Pharmacist Counseling and Immunization Rates]]>

Global review in The Lancet confirms mRNA vaccines are safe, effective, and promising for future disease treatment

Comprehensive review brings together global evidence to strengthen public trust and counter misinformation as mRNA vaccines expand to preven

Global review in The Lancet confirms mRNA vaccines are safe, effective, and promising for future disease treatment

Comprehensive review brings together global evidence to strengthen public trust and counter misinformation as mRNA vaccines expand to preven

COVID-19 made mRNA vaccines mainstream. WashU researchers say flu shots are next

Moderna's combined flu and COVID-19 mRNA vaccine shows durable immune response in mid-stage trial

A single dose of mRNA-1073 elicited durable immune responses through 6 months against all vaccine-matched influenza and SARS-CoV-2 strains.